Maintenance Therapy in Multiple Myeloma
Excerpt
The treatment of multiple myeloma (MM) has changed dramatically in the past twenty years with the introduction of high-dose therapy plus autologous stem-cell transplantation (ASCT) in younger patients and, more recently, of three novel agents (thalidomide, bortezomib, and lenalidomide) [...]
Share and Cite
Harousseau, J.-L. Maintenance Therapy in Multiple Myeloma. Hematol. Rev. 2009, 1, e12. https://doi.org/10.4081/hr.2009.e12
Harousseau J-L. Maintenance Therapy in Multiple Myeloma. Hematology Reviews. 2009; 1(2):e12. https://doi.org/10.4081/hr.2009.e12
Chicago/Turabian StyleHarousseau, Jean-Luc. 2009. "Maintenance Therapy in Multiple Myeloma" Hematology Reviews 1, no. 2: e12. https://doi.org/10.4081/hr.2009.e12
APA StyleHarousseau, J.-L. (2009). Maintenance Therapy in Multiple Myeloma. Hematology Reviews, 1(2), e12. https://doi.org/10.4081/hr.2009.e12